Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

NCT07610369 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07610369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Recruiting
Start date
July 10, 2026
Completion date
July 31, 2030
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, parkinson's disease (pd)